Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 2/20 | 0.61 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.61 |
| ▸ | MIF | P14174 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14701184 | 0.89 | MIF (0.60) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL15145063 | 0.87 | SLC16A3 (0.54) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL15491155 | 0.83 | MIF (0.50) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL15491157 | 0.83 | SLC16A3 (0.44) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL17732457 | 0.83 | MIF (0.54) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL17732463 | 0.82 | MIF (0.48) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL14252708 | 0.81 | SLC16A3 (0.61) | SLC16A3SLC16A1MIFALDH1A1MAPT | |
| SCHEMBL17732458 | 0.81 | MIF (0.49) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL17732462 | 0.80 | MIF (0.48) | SLC16A3SLC16A1MIFDNM1ALDH1A1 | |
| SCHEMBL14129152 | 0.79 | MAPT (0.48) | SLC16A3SLC16A1DNM1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | IK, CRY1, ABCG2 | SLC16A3 3417/4885SLC16A1 1755/4885MIF 2915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.